Showing 1,921 - 1,940 results of 63,851 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((teer decrease) OR (mean decrease)) ))', query time: 1.90s Refine Results
  1. 1921
  2. 1922

    mFIZZ1′ and mFIZZ1 decreased the IL-13 and IL-5 secretion of splenocytes. by Wael Gad (285901)

    Published 2013
    “…(<b>A</b>) Recombinant mFIZZ1′ and mFIZZ1 co-expressed with hQSOX1b significantly decreased the IL-5 secretion compared to the proteins expressed alone. …”
  3. 1923
  4. 1924
  5. 1925
  6. 1926

    <i>l</i>-THP decreased cardiac oxidative stress, TNF-α production and myocardial apoptosis. by Yi Han (194901)

    Published 2013
    “…Compared with the sham group, superoxide anion production significantly increased in vehicle group, while decreased in <i>l</i>-THP -treated group. <sup>#</sup>P<0.05 vs. sham group, *P<0.05 vs. vehicle group, n = 6. …”
  7. 1927
  8. 1928

    Knockdown of Ras decreases ERK phosphorylation and increases the DENV titers in <i>Aedes</i> mosquito cells. by Wen-Quan Liu (9323021)

    Published 2020
    “…<p><b>A</b> and <b>B</b>, knockdown of Ras decreased ERK phosphorylation in <i>Aedes</i> mosquito cells. …”
  9. 1929

    Depletion of endogenous RUNX1 protein in hematopoietic cells decreases occupancy and activity of RUNX1 P1 promoter. by Milka Martinez (2267155)

    Published 2016
    “…Asterisks indicate statistically significant decrease in expression of RUNX1 hnRNA (**p<0.01, ***p<0.001).…”
  10. 1930
  11. 1931
  12. 1932

    <i>Ex vivo</i> deletion of <i>sirt1</i> decreases expression of RUNX2 downstream targets. by Kayvan Zainabadi (502381)

    Published 2017
    “…<b>D)</b> Three other RUNX2 targets, Osteocalcin, Osteopontin, and Bone Sialoprotein (BSP), also show reduced expression in SIRT1 knockout cells (Cre), suggesting decreased transcriptional activity of RUNX2 in the absence of SIRT1. …”
  13. 1933
  14. 1934
  15. 1935
  16. 1936
  17. 1937
  18. 1938

    Top elevated (>1.30-fold and p value <0.1) and decreased (<1.30-fold and p value <0.1) proteins from serum exosomes of patients with Raynaud’s Phenomenon with positive ANA compared with serum exosomes from patients with Raynaud’s Phenomenon with negative ANA identified by aptamer proteomics. by Sonsoles Piera-Velazquez (14295451)

    Published 2022
    “…<p>Top elevated (>1.30-fold and p value <0.1) and decreased (<1.30-fold and p value <0.1) proteins from serum exosomes of patients with Raynaud’s Phenomenon with positive ANA compared with serum exosomes from patients with Raynaud’s Phenomenon with negative ANA identified by aptamer proteomics.…”
  19. 1939
  20. 1940